NCT04461509View on ClinicalTrials.gov

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions

Prostatic NeoplasmsGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleProstatic Disease

Interventions

DRUG

18F-PSMA

"Imaging (comparing standard and experimental high resolution diffusion-weighted imaging \[DWI\] MRI with 18F-PSMA)~Other Names:~18F-DCFPyL Injection prostate-cancer-specific radiotracer"

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors

collaborator

Progenics Pharmaceuticals, Inc.

INDUSTRY

lead

Alessandro D'Agnolo

OTHER

NCT04461509 - High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy | Biotech Hunter | Biotech Hunter